News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Minerva Biotechnologies Corporation Awarded Grant Under the Patient Protection and Affordable Care Act


11/5/2010 10:02:13 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Minerva Biotechnologies, a leading cancer and stem cell development company, today announced that it has been awarded a grant under the Patient Protection and Affordable Care Act. The Company received a grant of $244,479, which was the maximum allocation, to support its preclinical development of anti-cancer drugs that target a fundamental mechanism that drives the growth of 75% of cancers.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES